Market Research Report Store Prima BioMed Ltd (PRR) - Pharmaceuticals & Healthc | Page 4

Prima BioMed Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
Prima BioMed Ltd, Pharmaceuticals & Healthcare, Deal Details
Partnerships
10
11
11
Prima BioMed Enters into Agreement with Cytlimic
WuXi Biologics to Partner with Prima Biomed
11
11
Prima BioMed to Enter into Agreement with Krankenhaus Nordwest
12
Immutep Enters Into Development Agreement With Eddingpharm For ImmuFact IMP321
Licensing Agreements
13
14
Sydys Enters into Licensing Agreement with Prima BioMed
14
Prima BioMed Enters Into Licensing Agreement With Neopharm For CVac
CoStim Pharma Enters into Licensing Agreement with Immutep
15
16
Immutep Enters Into Licensing Agreement With GlaxoSmithKline For ImmuTune IMP731 16
Equity Offering
17
Prima BioMed Raises USD1.4 Million in Private Placement of Shares
17
Prima BioMed Raises USD1.14 Million in Private Placement of Shares 18
Prima BioMed Raises USD7.5 Million in Rights Offering of Shares
19
Prima BioMed Raises USD0.19 Million in Private Placement of Shares upon Exercise of Warrants
Prima BioMed Plans to Raise USD4 Million in Rights Offering of Shares
Prima BioMed to Raise USD1 Million in Private Placement of Shares
21
22
Prima BioMed Files Registration Statement For Public Offering Of American Depositary Shares For
US$60 Million
23
Prima BioMed Completes Second Tranche Of Private Placement Of Shares For US$3 Million
Prima BioMed Completes Private Placement Of Shares For US$1.3 Million
Prima BioMed Completes Private Placement Of Shares For US$1 Million
25
26
24
20